The Journal of Urology
Volume 179, Issue 2 , Pages 549-551, February 2008

Reprogramming Requirements After Sacral Nerve Stimulator Implantation: Correlation With Preoperative Indication

  • Kelly M. Maxwell
    • ,
  • J. Quentin Clemens

      Affiliations

    • Financial interest and/or other relationship with Merck, Pfizer, Novartis, Astellas and Medtronic.
    • ,
  • Laura Mazzenga
    • ,
  • Stephanie J. Kielb

      Affiliations

    • Corresponding Author InformationCorrespondence: Department of Urology, Feinberg School of Medicine, Northwestern University, 303 East Chicago Ave., Tarry 16-703, Chicago, Illinois 60611-3008 (telephone: 312-695-6124).

Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois

Received 25 June 2007 published online 12 December 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Study received institutional review board approval.

PII: S0022-5347(07)02573-6

doi:10.1016/j.juro.2007.09.071

The Journal of Urology
Volume 179, Issue 2 , Pages 549-551, February 2008

Article Tools